1994
Comparative
effects of quinine and cinchonine in reversing multidrug resistance
on human leukemic cell line K562/ADM
P. Genne,
O. Duchamp, E.
Solary, D. Pinard, J.P. Belon, M.T. Dimanche-Boitrel and B.
Chauffert
Leukemia,
1994
Jan, 8(1): 160-4
Liposomal
mitoxantrone for the local treatment of peritoneal carcinomatosis
induced by colon cancer cells in mouse
P. Genne,
N.O.
Olsson, G. Gutierrez, O. Duchamp and B. Chauffert
Anticancer
Drug Des., 1994 Apr, 9(2): 73-84
Mitoxantrone-Aracytine
avec ou sans quinine dans le traitement des leucémies aiguës
réfractaires ou en rechute (in French)
E.
Solary, F. Witz, P.
Moreau, I. Quiquandon, P. Genne, M. Flesch, A. Saddoun, F. Maloisel,
B. Pignon, J.F. Abgrall, D. Guyotat, P. Casassus, M. Gardembas, Y.
Lamy, B. Audhuy, C. Linassier, D. Caillot and J.L. Harousseau
Nouv
Rev Fr Hematol, 1994 Jul, 36 Suppl 2: S141-3
Deleterious
effect of serum proteins on the amphotericin B-induced potentiation
of cisplatin in human colon cancer cells
M. Assem,
S. Bonvalot,
J.L. Beltramo, C. Garrido, M.T. Dimanche-Boitrel, P. Genne, J.M.
Rebidou, D. Caillot and B. Chauffert
Br J Cancer,
1994 Oct,
70(4): 631-5
Confluence
dependent resistance to doxorubicin and E-cadherin expression in
murine mammary cells
M.T.
Dimanche-Boitrel, P. Genne, O.
Duchamp and B. Chauffert
Cancer
Letter, 1994 Oct 14, 85(2): 171-6
Evaluation
pré-clinique de la cinchonine, un puissant inhibiteur de la
résistance multidrogue (MDR) in vivo(Review in
French)
P.
Genne, O. Duchamp, D. Caillot, R.O. Casasnovas, H. Guy, E. Solary and
B.
Chauffert
Bull Cancer,
1994, 81: 936-7
1993
Mdr
1 gene-expression and villin synthesis in a colon cancer cell line
differentiated by sodium butyrate
J.M.
Petit, B.
Chauffert, M.T. Dimanche-Boitrel, P. Genne, O. Duchamp and F. Martin
Anticancer
Research, 1993 Mar-Apr,
13(2): 487-90
1992
Confluence-dependent
resistance in human colon cancer cells: role of reduced drug
accumulation and low intrinsic chemosensitivity of resting cells
M.T.
Dimanche-Boitrel, H.
Pelletier, P. Genne, J.M. Petit, C.
Le Grimelec, P. Canal, C. Ardiet, G. Bastian and B. Chauffert
Int
J Cancer, 1992 Mar 12, 50(5): 677-82
Chimiothérapie
expérimentale de carcinomatose péritonéale
d'origine colique chez le rat (in French)
B.
Chauffert, M.T.
Dimanche-Boitrel, P. Genne, N. Onier and J.F. Jeannin
Gastroenterol
Clin Biol, 1992, 16(3): 215-9
Histological
reactivity of monoclonal antibody against rat colon cancer cells on
human and rat normal gut and colonic tumors
P. Genne,
N.O.
Olsson, A. Caignard, R. Oriol, J. Bara, A. Hammann and F. Martin
Virchows Arch
A Pathol Anat
Histopathol., 1992, 420(3): 233-42
Cinchonine:
a potent efflux inhibitor to circumvent anthracycline resistance in
vivo
P.
Genne, M.T. Dimanche-Boitrel,
R.Y. Mauvernay, G. Gutierrez, O. Duchamp, J.M. Petit, F. Martin and B.
Chauffert
Cancer
Research, 1992 May 15, 52(10): 2797-801
1990
Mechanism
of resistance of confluent human and rat colon cancer cells to
anthracyclines: alteration of drug passive diffusion
H.
Pelletier, J.M. Millot, B. Chauffert, M. Mainfait, P. Genne and F.
Martin
Cancer
Research,
1990 Oct 15, 50(20): 6626-31
F11C
antigen: a membrane marker able to distinguish two regressive and
progressive variants from a rat colon adenocarcinoma
A.
Caignard, P. Genne, N.O. Olsson, R. Oriol and F. Martin
Int
J Cancer, 1990 Oct 15, 46(4): 633-9
1989
Serum
concentration of amiodarone required for an in vivo
modulation
of anthracycline resistance
P.
Genne, B. Coudert, H. Pelletier,
C. Girardot, F. Martin and B. Chauffert
Anticancer
Research, 1989
Nov-Dec, 9(6): 1655-9
1988
Use
of a specific monoclonal antibody for studying the liver metastatic
invasion of a rat colon cancer
B.
Chauffert, T. Shimizu, A.
Caignard, A. Hammann, P. Genne, H. Pelletier and M.S. Martin
In
Vivo, 1988 Sep-Oct, 2(5): 301-5
Home
Back
Top